Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Theriva Biologics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 32 | 31 | −1 |
| Shares | 8.52M | 6.50M | −2.01M (−23.6%) |
| Value | $5.80M | $3.91M | −$1.88M (−32.5%) |
New holders (6)
Institutions that held Theriva Biologics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 471,920 | $284.0K | 0.00% |
| Two Sigma Advisers, LP | 33,700 | $20.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 23,577 | $14.0K | 0.00% |
| Two Sigma Investments, LP | 21,775 | $13.0K | 0.00% |
| Sterneck Capital Management, LLC | 25,000 | $13.0K | 0.01% |
| Clearview Wealth Advisors LLC | 18,409 | $11.0K | 0.01% |
Sold out (7)
Institutions that held Theriva Biologics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Charles Schwab Investment Management Inc | 52,313 | $36.0K |
| tru Independence LLC | 60,000 | $30.0K |
| GWM Advisors LLC | 14,187 | $10.0K |
| Concord Wealth Partners | 1,000 | $1.00K |
| Barclays PLC | 495 | $0 |
| Sowell Financial Services LLC | 74 | $0 |
| PrairieView Partners, LLC | 487 | $0 |